Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control protein

Current Biology

Volumn 7, Issue 3, 1997, Pages 219-221

  Mittnacht, Sibylle ^a   Paterson, Hugh ^a   Olson, Michael F ^a   Marshall, Christopher J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031105404     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(97)70094-0     Document Type: Article

References (25)

1. Mulcahy LS, Smith MR, Stacey DW: Requirement for ras protooncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 1985, 313:241-243.
2. Feig LA, Cooper GM: Inhibition of NIH3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 1988, 8:3235-3243.
3. Adams PD, Kaelin WGJ: Transcriptional control by E2F. Semin Cancer Biol 1995, 6:99-108.
4. La Thangue NB: DTRF1/E2F: an extending family of heterodimeric factors implicated in cell cycle control. Trends Biochem Sci 1994, 19:108-114.
5. Sherr CJ: G1 phase progression: cycling on cue. Cell 1994, 79:551-556.
6. Furth ME, Davis LJ, Fleurdelys B, Scolnick EM: Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J Virol 1982, 43:294-304.
7. Warne PH, Viciana PR, Downward J: Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 1993, 364:352-355.
8. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA: Effects of an Rb mutation in the mouse. Nature 1992, 359:295-300.
9. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 1992, 70:993-1006.
10. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato JY, Livingston DM: Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 1993, 73:487-497.
11. Morgan DO: Principles of CDK regulation. Nature 1995, 374:131-134.
12. Sherr CJ: Cancer Cell Cycles. Science 1996, 274:1672-1677.
13. Stacey DW, Dobrowolski SF, Piotrkowski A, Harter ML: The adenovirus E1A protein overrides the requirement for cellular ras in initiating DNA synthesis. EMBO J 1994, 13:6107-6114.
14. Nevins JR: Cell targets of the DNA tumor viruses. Curr Opin Genet Dev 1994, 4:130-134.
15. Jansen-Durr P: How viral oncogenes make the cell cycle. Trends Genet 1996,12:270-275.
16. Stacey DW, DeGudicibus SR, Smith MR: Cellular ras activity and tumor cell proliferation. Exp Cell Res 1987,171:232-242.
17. Taylor SJ, Shalloway D: Cell cycle-dependent activation of Ras. Curr Biol 1996, 6:1621-1627.
18. Dobrowoski S, Harter M, Stacey DW: Cellular ras activity is required for passage through multiple points of the G0-G1 phase in BALB-c 3T3 cells. Mol Cell Biol 1994, 14:5441-5449.
19. Joneson T, White MA, Wigler MH, Bar-Sagi D: Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of Ras. Science 1996, 271:810-812.
20. de Vries Smits AMM, Burgering BMT, Leevers SJ, Marshall CJ, Bos JL: Involvement of p21ras in activation of extracellular signal-regulated kinase-2. Nature 1992, 357:602-604.
21. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry M, et al:. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994, 370:527-532.
22. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1995, 92:7686-7689.
23. Friend SH, Horowitz JM, Gerber MR, Wang XF, Bogenmann E, Li FP, Weinberg RA: Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci USA 1987, 84:9059-9063.
24. Morgenstern JP, Land H: Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complimentary helper-free packaging cell line. Nucleic Acids Res 1990, 18:3587-3596.
25. Pear W, Nolan G, Scott M, Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993, 90:8392-8396.